Variant report
Variant | rs859241 |
---|---|
Chromosome Location | chr17:15806122-15806123 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15805965..15808703-chr17:15809238..15811669,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs1102644 | 0.95[AFR][1000 genomes];0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11868331 | 0.93[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs11868613 | 0.80[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs11869184 | 0.80[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs11872072 | 0.87[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs1622059 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1622062 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1797463 | 0.90[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs2058366 | 1.00[EUR][1000 genomes] |
rs2482988 | 1.00[EUR][1000 genomes] |
rs2535600 | 1.00[EUR][1000 genomes] |
rs2535602 | 1.00[EUR][1000 genomes] |
rs2535604 | 1.00[EUR][1000 genomes] |
rs2779190 | 1.00[EUR][1000 genomes] |
rs2779191 | 1.00[EUR][1000 genomes] |
rs2779194 | 1.00[EUR][1000 genomes] |
rs2779203 | 1.00[EUR][1000 genomes] |
rs3859259 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4791645 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4791646 | 1.00[EUR][1000 genomes] |
rs4791651 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4791654 | 1.00[EUR][1000 genomes] |
rs4792695 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4792696 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4792697 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4792698 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs484520 | 1.00[EUR][1000 genomes] |
rs500752 | 0.84[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs513190 | 0.94[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs708592 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7209188 | 0.84[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs758854 | 1.00[EUR][1000 genomes] |
rs758855 | 1.00[EUR][1000 genomes] |
rs758856 | 1.00[EUR][1000 genomes] |
rs8079191 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs859225 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859227 | 1.00[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs859231 | 1.00[CHB][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859239 | 1.00[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs859242 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859244 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859245 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859246 | 0.95[AFR][1000 genomes];0.95[AMR][1000 genomes] |
rs859249 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859250 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859251 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859254 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859258 | 0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859259 | 0.94[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859260 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859261 | 0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859262 | 0.90[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859263 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859264 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859265 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859266 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859267 | 1.00[CHB][hapmap];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs859268 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv916652 | chr17:15093600-15856310 | Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 73 gene(s) | inside rSNPs | diseases |
2 | nsv1059056 | chr17:15294011-15856861 | Strong transcription Weak transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
3 | nsv934185 | chr17:15552960-16551197 | ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 190 gene(s) | inside rSNPs | diseases |
4 | nsv1062951 | chr17:15561070-15890644 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 24 gene(s) | inside rSNPs | diseases |
5 | nsv1066023 | chr17:15607267-16053512 | Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
6 | esv3330182 | chr17:15652014-16569534 | Strong transcription Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 177 gene(s) | inside rSNPs | diseases |
7 | esv3446844 | chr17:15654843-16572246 | Enhancers Strong transcription Flanking Active TSS Weak transcription ZNF genes & repeats Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 177 gene(s) | inside rSNPs | diseases |
8 | nsv1061222 | chr17:15672934-15999778 | ZNF genes & repeats Weak transcription Enhancers Active TSS Bivalent Enhancer Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
9 | nsv907706 | chr17:15731923-16056442 | ZNF genes & repeats Weak transcription Enhancers Active TSS Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
10 | esv1801208 | chr17:15789804-15807280 | Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Active TSS | Chromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
11 | esv1810041 | chr17:15789804-15807280 | Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
12 | esv1826171 | chr17:15789804-15807280 | Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
13 | esv1829876 | chr17:15789804-15807280 | Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
14 | esv1811790 | chr17:15790320-15807280 | Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
15 | nsv1067555 | chr17:15804228-16001117 | Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Enhancers Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
16 | nsv1063459 | chr17:15804228-16543593 | Weak transcription Flanking Active TSS Genic enhancers Enhancers ZNF genes & repeats Strong transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 164 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15796000-15811600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr17:15797200-15812600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr17:15805200-15811800 | Weak transcription | Pancreas | Pancrea |
4 | chr17:15805800-15806800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |